Mabylon
Agent44Agent Readiness: 44/100. Above median. Measured by StartupHub.ai. Median 41.Trust75Data Trust: 75/100. Above median. Measured by StartupHub.ai. Median 61.Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.
About
Mabylon AG is a clinical-stage biotechnology company focused on discovering and engineering novel antibody therapeutics for allergy, inflammation, and neurology. They leverage a technology platform that rapidly identifies and clones human-derived or immunized animal antibodies from diverse immune repertoires. Mabylon aims to select the best functional, therapeutically relevant antibody products to address unmet medical needs in these areas.
Similar companies
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
Shares Biotech, Drug Discovery
Biotechnology company developing novel immunotherapies for cancer.
Shares Biotech, MedTech
Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
Shares Biotech, MedTech
Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
Shares Biotech, Oncology
Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.
Shares Biotech, Drug Discovery
Key facts
- Website
- mabylon.com
- Headquarters
- Geneva, Switzerland
- Total funding
- $36M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 28 May 2024 | Series A | $34M | EIC Fund, Vesalius Biocapital IV |
| 1 May 2024 | Undisclosed round | $2M | Sofinnova Partners, BioGeneration Ventures |
Tech stack
Detected on mabylon.com, last scanned 31 Oct 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Backend
- PHP
- Analytics
- Google Analytics 4
- Email provider
- Microsoft 365
Mabylon scores 33. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Mabylon trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Mabylon is 75 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Mabylon raised?
Mabylon has raised a total of $36M in funding. The most recent round on record is Series A.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Mabylon
